Syon Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Syon Capital's IBB Position: Q3 2026 in Review
Syon Capital reduced its iShares Biotechnology ETF (IBB) stake by 12% in Q3 2026, selling an estimated $34.1K and leaving 1,264 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #976.
Syon Capital first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.02M in Q4 2024. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Syon Capital held 1,264 shares of iShares Biotechnology ETF worth $266K as of Q3 2026.
- Syon Capital sold 170 iShares Biotechnology ETF shares in Q3 2026, an estimated $34.1K.
- iShares Biotechnology ETF made up 0.01% of Syon Capital's portfolio in Q3 2026, its #976 holding.
- Syon Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
- Syon Capital's iShares Biotechnology ETF position peaked at $1.02M in Q4 2024.
- 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.